Search
Close this search box.

Crystal structures of three 4-[3-(XC6H4)-hexahydro[1,3] oxazolo[3,4-a]pyridin-1-yl]-2,8-bis(trifluoromethyl)quinolines (X = 3-MeO, 4-MeO and 4-HO)

Authors: De Souza, M.V.N.; Gonçalves, R.S.B.; Wardell, S.M.S.V.; Wardell, J.L.


Abstract

The crystal structures of three racemic 4-{3- (X-phenyl)hexahydro[1,3]oxazolo[3,4-a]pyridin-1-yl}-2,8- bis (trifluoromethyl)quinolines, 2, namely (2: X = 3-MeO, 4-MeO and 4-HO), prepared from mefloquine and XC6H5CHO, are reported. All three molecules were previously reported to be active in in-vitro studies against the multidrug-resistant tuberculosis strain T113. In each of the three molecules, the piperidinyl ring has a chair shape with substituents in equatorial sites and the 1,3-oxazolidinyl ring exhibit deviations from planarity. All molecules have “F’’ shape conformations with the X-phenyl and quinoline rings lying on one side of the best plane through the fused oxazolidine-piperidine rings, and in an arrangement approaching open butterfly wings. However there are differences in the inter-planar angles. No correlation was established between the anti-TB activity and the molecular conformation. Compound (2: X = 4-MeO) has a onedimensional structure generated from C-F … π(pyridine) and C-H … π(methoxyphenyl) interactions. Both (2: X = 3-MeO) and (2: X = 4-HO) have three dimensional structures. The supramolecular arrangements in (2: X = 3-MeO) are derived from C-H … O(oxazolidine), C-H … F and C-H … π(phenyl of quinoline) interactions and those for (2: X = 4-HO) from O-H … N(piperidine), C-H … O(hydroxyl), C-H … F, C-H … π(phenyl of quinoline), C-F … π(pyridine), C-F … π(imine) and p(methoxyphenyl) … π(methoxyphenyl) interactions.
Keywords: X-ray crystallography; Quinoline derivatives; Mefloquine derivatives; Oxazolidines; Anti-TB agents Document Type: Research Article DOI: http://dx.doi.org/10.1524/zkri.2013.1618 Publication date: 1 de agosto de 2013

Compartilhar publicação

Facebook
Twitter
Email
LinkedIn
WhatsApp

Deixe seu comentário

Compartilhar

Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes